BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1320297)

  • 41. In Silico Mathematical Modelling for Glioblastoma: A Critical Review and a Patient-Specific Case.
    Falco J; Agosti A; Vetrano IG; Bizzi A; Restelli F; Broggi M; Schiariti M; DiMeco F; Ferroli P; Ciarletta P; Acerbi F
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34067871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.
    Protopapa M; Zygogianni A; Stamatakos GS; Antypas C; Armpilia C; Uzunoglu NK; Kouloulias V
    J Neurooncol; 2018 Jan; 136(1):1-11. PubMed ID: 29081039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal weekly scheduling in fractionated radiotherapy: effect of an upper bound on the dose fraction size.
    Bruni C; Conte F; Papa F; Sinisgalli C
    J Math Biol; 2015 Aug; 71(2):361-98. PubMed ID: 25168624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dealing with diversity in computational cancer modeling.
    Johnson D; McKeever S; Stamatakos G; Dionysiou D; Graf N; Sakkalis V; Marias K; Wang Z; Deisboeck TS
    Cancer Inform; 2013; 12():115-24. PubMed ID: 23700360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In silico modelling of treatment-induced tumour cell kill: developments and advances.
    Marcu LG; Harriss-Phillips WM
    Comput Math Methods Med; 2012; 2012():960256. PubMed ID: 22852024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The HYP-RT hypoxic tumour radiotherapy algorithm and accelerated repopulation dose per fraction study.
    Harriss-Phillips WM; Bezak E; Yeoh E
    Comput Math Methods Med; 2012; 2012():363564. PubMed ID: 22778783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal solution for a cancer radiotherapy problem.
    Bertuzzi A; Bruni C; Papa F; Sinisgalli C
    J Math Biol; 2013 Jan; 66(1-2):311-49. PubMed ID: 22314975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploiting clinical trial data drastically narrows the window of possible solutions to the problem of clinical adaptation of a multiscale cancer model.
    Stamatakos GS; Georgiadi EC; Graf N; Kolokotroni EA; Dionysiou DD
    PLoS One; 2011 Mar; 6(3):e17594. PubMed ID: 21407827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Introduction of hypermatrix and operator notation into a discrete mathematics simulation model of malignant tumour response to therapeutic schemes in vivo. Some operator properties.
    Stamatakos GS; Dionysiou DD
    Cancer Inform; 2009 Oct; 7():239-51. PubMed ID: 20011462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical parameters determining standard radiotherapy treatment outcome for glioblastoma multiforme: a computer simulation.
    Dionysiou DD; Stamatakos GS; Gintides D; Uzunoglu N; Kyriaki K
    Open Biomed Eng J; 2008 Sep; 2():43-51. PubMed ID: 19662116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Medicine and technique: computer simulations in cancer research].
    Düchting W
    Med Klin (Munich); 1998 Sep; 93(9):565-70. PubMed ID: 9792026
    [No Abstract]   [Full Text] [Related]  

  • 52. Radiogenic responses of normal cells induced by fractionated irradiation--a simulation study. Part II. Late responses.
    Düchting W; Ulmer W; Ginsberg T; Kikhounga-N'Got O; Saile C
    Strahlenther Onkol; 1995 Sep; 171(9):525-33. PubMed ID: 7570301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computer simulation of clinical irradiation schemes applied to in vitro tumor spheroids.
    Düchting W; Lehrig R; Rademacher G; Ulmer W
    Strahlenther Onkol; 1989 Dec; 165(12):873-8. PubMed ID: 2603123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
    Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computer simulation and modelling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy.
    Düchting W; Ulmer W; Lehrig R; Ginsberg T; Dedeleit E
    Strahlenther Onkol; 1992 Jun; 168(6):354-60. PubMed ID: 1320297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computer simulation of fractionated radiotherapy: further results and their relevance to percutaneous irradiation and brachytherapy.
    Ginsberg T; Ulmer W; Düchting W
    Strahlenther Onkol; 1993 May; 169(5):304-10. PubMed ID: 8503090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling of radiogenic responses induced by fractionated irradiation in malignant and normal tissue.
    Düchting W; Ginsberg T; Ulmer W
    Stem Cells; 1995 May; 13 Suppl 1():301-6. PubMed ID: 7488961
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.